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Abstract
Introduction: Chylothorax is a rare complication of surgical neck dissection. This is the first reported pediatric case
of bilateral chylothorax following cervical surgery and the first to occur after tracheoplasty. Chylothorax can lead to
significant complications, including hypoxemia and shock, and requires timely treatment. This case report discusses
the clinical presentation, diagnosis, and treatment of our patient and reviews possible pathophysiologic
mechanisms to explain the development of postoperative bilateral chylous effusions.
Case presentation: An 18-month-old white baby girl with a complex past medical history including choanal atresia,
atrioventricular septal defect, failure to thrive, developmental delay, and tracheostomy dependence developed
significant hypoxemia and shock following a routine tracehostomy revision. She was subsequently found to have
developed massive bilateral chylothorax, requiring escalation of mechanical ventilation, thoracostomy tube drainage,
vasoactive support, and eventual surgical ligation of her thoracic duct.
Conclusions: Massive bilateral chylothorax is a rare but potentially life-threatening complication following
tracheoplasty. Clinicians caring for this patient population postoperatively should be aware of this potential
complication and its management.
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Introduction
Chylothorax is the accumulation of chyle in the pleural
space due to disruption or obstruction of the thoracic duct.
Chyle is lymphatic fluid absorbed from the intestinal tract; it
is rich in triglycerides, lymphocytes, immunoglobulins, and
other small-molecular-weight proteins. Chyle is transported
from the intestinal tract to the upper central venous system
by the thoracic duct. The thoracic duct begins at the cis-
terna chyli located at the level of the first or second lumbar
vertebra. It enters into the thoracic cavity via the aortic hia-
tus and continues to ascend in the posterior mediastinum
between the aorta and the azygous vein. At the fifth thor-
acic vertebral level, the duct crosses over from the right
side to the left and continues its course until it reaches
and empties into venous circulation. The termination
point is highly variable but most commonly occurs at the
junction of the left internal jugular and subclavian veins.
The etiology of chylothorax can be divided into four cat-
egories: malignancy, trauma, idiopathic, and miscellaneous.
Traumatic chylothorax most commonly occurs as a com-
plication of thoracic surgery [1]. In the pediatric population,
traumatic chylothorax is associated most frequently with
cardiothoracic surgery for congenital heart disease with
a reported incidence of 8.9% at this institution [2]. Chy-
lothorax following neck surgery, on the other hand, is rare.
To date, only 22 cases of bilateral chylothorax as a compli-
cation of neck dissection have been reported in the English
literature, all described in adult patients. These have
occurred almost exclusively in the setting of radical neck
dissection for various malignancies. Typical management
has included thoracentesis, thoracostomy tube drainage,
low fat diet or nil by mouth (NPO) and, in rare instances,
thoracic duct ligation.
Diagnosis of chylothorax usually begins with radio-
graphic imaging revealing a pleural effusion on chest
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X-ray after development of respiratory distress. The
diagnosis of chylothorax requires laboratory evalu-
ation of pleural fluid in order to differentiate it from
other types of pleural effusion. The presence of chylo-
microns is diagnostic. Table 1 lists pleural fluid la-
boratory characteristics of chylothorax [3].
The management approach for chylothorax is variable.
Management initially involves dietary modification to
reduce chyle flow as well as somatostatin analogs to reduce
lymphatic flow. Drainage of pleural fluid may be necessary
if it causes respiratory distress. The patient must be moni-
tored for sequelae from chyle loss and abnormalities cor-
rected. Conservative management is often successful but
surgical management is occasionally necessary. A system-
atic trial of conservative treatment for 7 to 10 days followed
by tiered surgical intervention can minimize the length of
Intensive Care Unit (ICU) stay, hospital stay, and length of
medical device use [2].
Here we present the first pediatric case of bilateral
chylothorax after cervical surgery and the first case of
chylothorax following tracheostoma revision.
Case presentation
An 18-month-old white baby girl who is tracheostomy
and ventilator dependent underwent cartilage graft
tracheoplasty and developed the postoperative complica-
tion of bilateral chylothorax. Her past medical history is
complex and includes choanal atresia, atrioventricular
septal defect, complete heart block, congestive heart fail-
ure, failure to thrive, tracheobronchomalacia, develop-
mental delay, and hypothyroidism. Her past surgical
history is significant for bilateral choanal atresia repair,
patent ductus arteriosus (PDA) ligation at age 1 month,
partial atrial septal defect/ventricular septal defect
(ASD/VSD) closure at age 2 months, subsequent cardiac
pacemaker implantation at age 2 months complicated by
implant infection requiring explantation at age 3
months. Due to heart failure and tracheobronchomala-
cia, she underwent tracheostomy at age 3 months with
an intraoperative note of continuity of the cervical field
with the mediastinal surgical fields. Her pacemaker was
replaced at age 4 months and was complicated by left
chylothorax, which resolved with chest tube drainage
and NPO diet with parenteral nutrition. Other significant
procedures include gastrojejunostomy (GJ) tube placement
at age 5 months complicated by small bowel perforation
requiring open repair.
She was first discharged home after birth at age 9 months
with a cuffed tracheostomy tube, ventilator dependent, and
gastrostomy tube dependent. During out-patient follow-up,
evaluation of her tracheostomy site revealed significant
inferior tracheostoma breakdown with difficulty maintain-
ing a seal for adequate airway pressures as well as imminent
innominate artery exposure. She was also noted to have
significant hearing loss due to chronic otitis media with ef-
fusion. Pediatric surgery separately evaluated her gas-
trostomy tube with leakage noted around the site.
Therefore tracheoplasty, bilateral myringotomy and
tympanostomy tube insertion, and gastrostomy tube
revision were scheduled.
She underwent combined procedures with otolaryngol-
ogy and pediatric surgery under a single anesthetic.
Bilateral myringotomy and tympanostomy, direct laryn-
goscopy, bronchoscopy, and anterior cartilage graft tra-
cheoplasty were performed by otolaryngology. Pediatric
surgery performed gastrocutaneous fistula closure and
Broviac catheter placement. During the skin incision for
tracheoplasty, an obvious chyle leak was encountered just
deep to the skin and 2mm left of the tracheostoma. This
was controlled using a figure-of-eight stitch with a 2–0 silk
suture. No further chyle leak was detected during the
remainder of the case.
Postoperatively she was admitted to the pediatric ICU.
On the third postoperative day, she developed worsening
hypoxemia and respiratory distress. The ventilator was
escalated from home settings of peak inspiratory pres-
sure (PIP) 24cmH2O, positive end-expiratory pressure
(PEEP) 8cmH2O, and fraction of inspired oxygen (FiO2)
21% to PIP 30cmH2O, PEEP 12cmH2O, and FiO2 45%.
A chest X-ray revealed a large right pleural effusion and
a smaller left pleural effusion (Fig. 1). Given clinical
decompensation, the decision was made to drain the
effusions. An 8.5 French pigtail drain was inserted in the
right pleural space and thoracentesis was performed on
the left pleural effusion. A total of 130mL of milky
fluid was drained from the right pleural space prior
to placement of a chest tube drainage system. A total
of 30mL of milky fluid was drained from the left. The
left effusion accumulated over the next 24 hours
prompting placement of a chest tube on postoperative
day 4. Pleural fluid laboratory studies were sent and
were diagnostic for a chylous effusion (Table 2). Other
diagnostic considerations included hemothorax, simple
effusion secondary to heart failure, or empyema secondary
to pneumonia.
The patient proceeded to have significant chest tube
output particularly from the right side (>130mL/kg/day).
Table 1 Pleural fluid laboratory characteristics of chylous effusion
Appearance Variable (milky, sanguineous, serous)
Lipoprotein analysis Presence of chylomicrons
Cell count Lymphocyte predominance
pH Alkaline
Triglycerides Typically >110mg/dL
Lactate dehydrogenase Exudative range
Protein 2–3mg/dL
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Output was significant enough to cause hemodynamic
instability. Four 10ml/kg fluid boluses with either 0.9%
normal saline or 5% albumin were administered for
hypotension during the first 24 hours post-chest tube
placement. Due to continued significant chest tube
drainage and subsequent fluid refractory hypotension,
vasoactive support was provided with an epinephrine
infusion for 3 days. In order to prevent further
hemodynamic instability from chest tube losses, ml per
ml volume replacement of chest tube output with 5%
albumin was started.
She met our institution’s criteria for high-output chy-
lothorax (>20mL/kg/day), and treatment was initiated
according to protocol [2]. An NPO diet with parenteral
nutrition and octreotide infusion (3mcg/kg/hour) were
ordered for 8 days. Following this, the left chylothorax
resolved but right chylous output remained high. There-
fore, we elected to proceed with thoracic duct ligation.
Ligation was performed via right thoracotomy on postop-
erative day 12. Octreotide was discontinued postopera-
tively while NPO status with parenteral nutrition was
continued for 3 more days. An enteral diet was introduced
5 days post-procedure with no further chyle leak. All chest
tubes were subsequently removed and she was discharged
home 10 days after thoracic duct ligation. She continued
on a medium-chain fatty acid diet for 6 weeks following
thoracic duct ligation. She has had no further complica-
tions from her chylothorax.
Discussion
This is the first known report of bilateral chylothorax
after neck surgery in a pediatric patient as well as the
first known report of chylothorax following tracheos-
toma revision.
Given the anatomical structure of the thoracic duct,
postsurgical chylothorax tends to occur unilaterally. Thor-
acic duct injury below the fifth thoracic vertebral body
usually results in a right-sided pleural effusion while injury
above usually results in a left-sided effusion [4]. Although
Fig. 1 Chest X-ray images of pleural effusions. a Bilateral pleural effusions noted on postoperative day 3. b Following right chest tube placement and
left thoracentesis on postoperative day 3. c Reaccumulation of left pleural effusion on postoperative day 4. d Following left chest tube placement on
postoperative day 4
Table 2 Pleural fluid laboratory results
Appearance Opaque
Color Yellow
Red blood cell count <3000 cells/mm3







Lactate dehydrogenase 124 IU/L
Protein 3.1gm/dL
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not uncommon following thoracic surgery, chylothorax
following neck dissection is rare with a reported incidence
of 1 to 2% [5]. When it occurs, it usually results in a left-
sided effusion.
Treatment recommendations for chylothorax are variable
[5–7] but prudent management should include low-risk
nonoperative treatments initially. Aside from identification
and treatment of the underlying cause, the initial therapy
should involve dietary modification to reduce chyle flow
using a low fat or NPO diet. If dietary modification is not
adequate, then administration of somatostatin or an analog
such as octreotide can be considered. Somatostatin works
by directly acting on somatostatin receptors reducing
lymphatic fluid production, thereby reducing chyle flow. In
cases where cardiorespiratory status is compromised, thor-
acentesis with thoracostomy tube placement should be
performed and appropriate ventilatory support provided.
Common clinical practice is a trial of conservative manage-
ment with dietary modification and/or octreotide for ap-
proximately 1 to 2 weeks. If output remains high after this
time or spontaneous healing is unlikely, consultation with
a cardiothoracic surgeon should occur soon after diagnosis
to determine indications for thoracic duct ligation. Early
surgical intervention in cases of high-flow chyle leak failing
medical therapy can reduce hospital stay, ICU stay, and the
use of intensive care medical devices [2].
Aside from direct management of chyle leak, patients
require close monitoring for complications of chyle
loss. Chyle contains triglycerides, small-molecular weight
proteins (albumin, immunoglobulin), and lymphocytes.
Therefore, patients are at risk for malnutrition, hypovol-
emia, metabolic and electrolyte abnormalities, and im-
munodeficiency. If enteral nutrition is possible, a fat-free
diet can be instituted using a medium-chain triglyceride
formula. Medium-chain triglycerides are saturated fatty
acids that are of 8 to 12 carbon lengths and their use is
indicated in chylothorax because they are directly taken
up by portal circulation, bypassing lymphatic circulation.
Response to a medium-chain triglyceride diet should
be seen within the first week with full resolution of
the chylothorax by the end of the second week (goal
<10mL/kg/day) [8]. If enteral dietary modification fails or
is not an option due to severity of chylothorax, then full
NPO status is required with total parenteral nutrition and
lipids to maintain nutritional status.
Hypovolemia can result if a chyle leak is significant
enough from both general volume loss and albumin loss
[9]. Hypoalbuminemia can exacerbate hypotension due to
third spacing that occurs secondary to reduced oncotic
pressure. Intravascular resuscitation with fluid boluses
may be necessary and repletion of ongoing chyle loss with
ml per ml replacement fluid should be considered. Albu-
min levels should be followed closely and replacement
with concentrated albumin considered for level <3g/dL,
specifically in critically ill patients [10, 11]. Electrolyte and
acid–base derangements can develop with hyponatremia,
hypocalcemia, and metabolic acidosis of particular con-
cern [12]. Lastly, secondary immunodeficiency can occur
due to loss of both immunoglobulins and lymphocytes
[13]. Routine immunoglobulin replacement with immuno-
globulin administered intravenously (IVIG) for hypogam-
maglobulinemia has not demonstrated a protective effect
for pediatric patients with chylothorax [14] but should be
considered for patients who have additional risk factors
for serious infection.
While our patient did have a cervical chyle leak identified
and repaired intraoperatively, the development of massive
bilateral chylothorax following cervical surgery remains
puzzling. There was no intrathoracic injury to the thoracic
duct nor was there injury to the pleura evidenced by the
absence of pneumothorax. Two pathophysiologic mecha-
nisms have been suggested as the etiology of chylothorax
after cervical surgery. The first is direct leakage of chyle
into the mediastinum from the thoracic duct. Leakage of
chyle results in an inflammatory reaction that allows pene-
tration of chylous fluid from the mediastinum into the
pleural space through the inflamed pleura. The second is
ligation of the distal thoracic duct, which leads to increased
hydrostatic pressure within the fragile lymphatic vessels.
The build-up of pressure within the thoracic duct, com-
bined with negative intrathoracic pressure, leads to either
rupture or non-traumatic leakage of chyle into the medias-
tinum and pleural spaces [3, 10]. Either of these mecha-
nisms could have contributed to the development of
bilateral chylothorax in our patient.
Conclusions
In summary, chylothorax is a rare complication of neck
surgery. This is the first reported pediatric case of bilat-
eral chylothorax following cervical surgery and the first
to occur after tracheoplasty. Clinicians caring for pa-
tients after neck dissection should be aware of this rare
but significant complication and the various strategies
for effective treatment.
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